Hormone Therapy for Postmenopausal Women with Urinary Incontinence
Metadata[+] Show full item record
Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence. Hormone therapy is associated with worsening urinary incontinence in postmenopausal women who are incontinent at baseline (Strength of Recommendation [SOR]: A, based on a systematic review) and is associated with an increased risk of developing urinary incontinence in those who are continent at baseline (SOR: A, based on two large randomized controlled trials [RCTs]).
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.